Clinical Trial Update: Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 2-6 Years [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Sinovac's Group ACYW135 meningococcal conjugate vaccine in children aged 2-6 years; the study is currently NOT_YET_RECRUITIN…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningitis
• Meningococcal Disease

Drugs mentioned

• Group ACYW135 Meningococcal Conjugate Vaccine (Meningococcal conjugate vaccine ACYW135)

Snippet

Sponsor: Sinovac Biotech Co., Ltd | Conditions: Epidemic Meningitis, Meningococcal Vaccines | Phase 3 | Status: NOT_YET_RECRUITING